Screening extended-spectrum beta-lactamase production in Enterobacter cloacae and Serratia marcescens using antibiogram-based methods (Q43077883)

13 November 2017

Screening extended-spectrum beta-lactamase production in Enterobacter cloacae and Serratia marcescens using antibiogram-based methods (English)

1 reference

13 November 2017

Serratia marcescens

1 reference

Enterobacter cloacae

1 reference

Po-An Su

1

1 reference

13 November 2017

Lii-Tzu Wu

2

1 reference

13 November 2017

Kuo-Chen Cheng

3

1 reference

13 November 2017

Wen-Chien Ko

4

1 reference

13 November 2017

Yin-Ching Chuang

5

1 reference

13 November 2017

Wen-Liang Yu

6

1 reference

13 November 2017

1 February 2010

1 reference

Journal of Microbiology Immunology and Infection

13 November 2017

1 reference

13 November 2017

43

1 reference

13 November 2017

1

1 reference

13 November 2017

26-34

1 reference

A functional classification scheme for beta-lactamases and its correlation with molecular structure

13 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960004-7

7 January 2021

Extended-spectrum beta-lactamases and other enzymes providing resistance to oxyimino-beta-lactams

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960004-7

7 January 2021

Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960004-7

7 January 2021

A 1998 survey of extended-spectrum beta-lactamases in Enterobacteriaceae in France. The French Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960004-7

7 January 2021

Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960004-7

7 January 2021

Controversies about extended-spectrum and AmpC beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960004-7

7 January 2021

Prevalence of extended-spectrum beta-lactamase-producing Enterobacter cloacae in the Asia-Pacific region: results from the SENTRY Antimicrobial Surveillance Program, 1998 to 2001.

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960004-7

7 January 2021

Occurrence of extended-spectrum beta-lactamases among chromosomal AmpC-producing Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens in Korea and investigation of screening criteria

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960004-7

7 January 2021

Contribution of chromosomal beta-lactamases to beta-lactam resistance in enterobacteria.

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960004-7

7 January 2021

Common mechanism of ampC beta-lactamase induction in enterobacteria: regulation of the cloned Enterobacter cloacae P99 beta-lactamase gene

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960004-7

7 January 2021

Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns.

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960004-7

7 January 2021

Comparison of five different methods for detection of SHV extended-spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960004-7

7 January 2021

Evaluation of Oxoid combination discs for detection of extended-spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960004-7

7 January 2021

Dissemination of extended-spectrum beta-lactamase-producing Enterobacteriaceae in pediatric intensive care units

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960004-7

7 January 2021

Nosocomial and community-acquired Enterobacter cloacae bloodstream infection: risk factors for and prevalence of SHV-12 in multiresistant isolates in a medical centre

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960004-7

7 January 2021

Variety of TEM-, SHV-, and CTX-M-type beta-lactamases present in recent clinical isolates of Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae from Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960004-7

7 January 2021

Development of a multiplex PCR and SHV melting-curve mutation detection system for detection of some SHV and CTX-M beta-lactamases of Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960004-7

7 January 2021

Characterisation and molecular epidemiology of extended-spectrum beta-lactamase-producing Enterobacter cloacae isolated from a district teaching hospital in Taiwan.

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960004-7

7 January 2021

Confirmation of extended-spectrum beta-lactamase-producing Serratia marcescens: preliminary report from Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960004-7

7 January 2021

Survey of CTX-M-3 extended-spectrum beta-lactamase (ESBL) among cefotaxime-resistant Serratia marcescens at a medical center in middle Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960004-7

7 January 2021

CTX-M-14, a plasmid-mediated CTX-M type extended-spectrum beta-lactamase isolated from Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960004-7

7 January 2021

Dissemination of SHV-12 and characterization of new AmpC-type beta-lactamase genes among clinical isolates of enterobacter species in Korea

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960004-7

7 January 2021

High prevalence of extended-spectrum beta-lactamase-producing strains among blood isolates of Enterobacter spp. collected in a tertiary hospital during an 8-year period and their antimicrobial susceptibility patterns.

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960004-7

7 January 2021

Prevalence of extended-spectrum beta-lactamases in isolates of the Enterobacter cloacae complex from German hospitals.

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960004-7

7 January 2021

SHV-type extended-spectrum beta-lactamase production is associated with Reduced cefepime susceptibility in Enterobacter cloacae

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960004-7

7 January 2021

Activities of beta-lactam antibiotics against Escherichia coli strains producing extended-spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960004-7

7 January 2021

Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum beta-lactamase-producing Enterobacteriaceae

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960004-7

7 January 2021

10.1016/S1684-1182(10)60004-7

Identifiers

DOI

1 reference

release_gc4ytwpdyfhihmfby4jyu2d6ay

13 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/gc4ytwpdyfhihmfby4jyu2d6ay

24 November 2022

mapped directly with Wikidata item

1 reference